ALA‐10 MUTATIONS IN THE FACTOR IX PROPEPTIDE AND HAEMORRHAGE IN A PATIENT TREATED WITH WARFARIN
Peter Baker(Oxford University Hospitals NHS Trust), David Keeling(Hampton Roads Sanitation District), Kevin Clarke, Paul Giangrande
Cited by 10
Related Papers
Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders
|Journal of Thrombosis and Haemostasis|2012|498
Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′‐untranslated region of the prothrombin gene
|British Journal of Haematology|1997|158
Renal artery dissection causing renal infarction in otherwise healthy men
|American Journal of Kidney Diseases|1997|67
Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis
|British Journal of Haematology|2020|63
Clinical and laboratory diagnosis of heritable platelet disorders in adults and children: a British Society for Haematology Guideline
|British Journal of Haematology|2021|39